Vigamox and Nasacort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vigamox (moxifloxacin hydrochloride) and Nasacort (triamcinolone acetonide). Common drug interactions include diarrhoea among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Vigamox and Nasacort. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Vigamox?

Vigamox has active ingredients of moxifloxacin hydrochloride. It is often used in conjunctivitis. eHealthMe is studying from 2,899 Vigamox users. Check the latest studies of Vigamox.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.



On Jul, 06, 2026

14 people who take Vigamox and Nasacort together, and have interactions are studied.

Vigamox and Nasacort drug interactions.

What are the common drug interactions of Vigamox and Nasacort, by gender? *:

female:

  1. Diarrhoea
  2. Dysarthria (speech disorder)
  3. Dyskinesia (abnormality or impairment of voluntary movement)
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Dyspnoea (difficult or laboured respiration)
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Emotional disorder
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  9. Endocarditis (inflammation in heart muscle)
  10. Erythema (redness of the skin)

male:

  1. Pain
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Acquired cardiac septal defect (hole in the heart)
  4. Anaemia (lack of blood)
  5. Anxiety
  6. Apnoea (suspension of external breathing)
  7. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Atrial tachycardia (rhythm disturbance that arises in the atria)

What are the common drug interactions of Vigamox and Nasacort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Chest discomfort
  2. Dyspnoea (difficult or laboured respiration)
  3. Influenza like illness
  4. Pain
  5. Vomiting

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

  1. Chronic kidney disease

60+:

  1. Abdominal distension
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Ventricular extrasystoles (premature cardiac contraction)
  5. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  6. Chronic kidney disease
  7. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  8. Renal failure (kidney dysfunction)
  9. Acquired cardiac septal defect (hole in the heart)
  10. Anaemia (lack of blood)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 50.00%
  2. High Blood Cholesterol: 6 people, 42.86%
  3. Asthma: 5 people, 35.71%
  4. Diabetes: 5 people, 35.71%
  5. High Blood Pressure: 4 people, 28.57%
  6. Pain: 4 people, 28.57%
  7. Multiple Allergies (allergy to multiple agents): 3 people, 21.43%
  8. Insomnia (sleeplessness): 3 people, 21.43%
  9. Infection: 3 people, 21.43%
  10. Indigestion: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Vigamox and Nasacort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vigamox and Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vigamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vigamox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasacort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on moxifloxacin hydrochloride and triamcinolone acetonide (the active ingredients of Vigamox and Nasacort, respectively), and Vigamox and Nasacort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: